Session 3: Immunotherapy and Immune Prevention

This session focuses on Immunotherapy and Immune Prevention in relation to Lynch syndrome. The following lectures are included in this session, in addition to a panel Q&A at the conclusion:
1. Exercise Induced Mucosal Response by Eduardo Vilar-Sanchez, MD, PhD from MD Anderson Cancer Center
2. Immune Checkpoint Inhibitor Therapy for Early-Stage Lynch Syndrome Cancers by Michael Foote, MD from Memorial Sloan Kettering Cancer Center
3. Immunoprevention and Upcoming Vaccine Trials by Eduardo Vilar-Sanchez, MD, PhD from MD Anderson Cancer Center